CD5 and CD23 expression on B cells in peripheral blood and synovial fluid of rheumatoid arthritis patients: relationship with interleukin-4, soluble CD23 and tumour necrosis factor alpha levels

Citation
E. Loza et al., CD5 and CD23 expression on B cells in peripheral blood and synovial fluid of rheumatoid arthritis patients: relationship with interleukin-4, soluble CD23 and tumour necrosis factor alpha levels, RHEUMATOLOG, 38(4), 1999, pp. 325-328
Citations number
38
Categorie Soggetti
Rheumatology
Journal title
RHEUMATOLOGY
ISSN journal
14620324 → ACNP
Volume
38
Issue
4
Year of publication
1999
Pages
325 - 328
Database
ISI
SICI code
1462-0324(199904)38:4<325:CACEOB>2.0.ZU;2-M
Abstract
Methods. We have studied in peripheral blood (PB) and synovial fluid (SF) o f 31 patients diagnosed with rheumatoid arthritis (RA), the expression of C D5 and CD23 antigens on B cells, and the levels of soluble CD23 (sCD23), in terleukin-4 (IL-4) and tumour necrosis factor alpha (TNF-cr). We have also correlated the results with the disease activity index. Results. CD5 + B cells are expanded in SF and, moreover, show higher expres sion of CD23 than CD5 - B cells. Twelve patients had detectable levels of I L-4 in plasma and 10 in SF (nine patients in both samples); the absence of IL-4 was related to a higher expression of CD23 on CD5 + B cells and with h igher levels of sCD23. A negative correlation was found in SF between TNF-a lpha and sCD23 levels. Conclusion. There is no correlation between disease activity index and the different parameters studied (expression of CD5 and CD23 on B cells, sCD23, IL-4 acid TNF-a levels) either in plasma/PB or in SF.